Moreover, a correlation of elevated survivin expression with increased risk of recurrences, lymph node metastases, and shorter survival was shown beside others, in non-small cell lung cancer (NSCLC), T1 bladder carcinoma [7], rectal adenocarcinoma [8] and locally advanced prostate cancer [9] treated with radiation therapy or chemoradiation. Here, BIRC5 is linked to metastatic malignant neoplasm in the lymph nodes.